Quantum BioPharma Ltd (NASDAQ:QNTM) price on Thursday, July 03, fall -10.96% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $17.06.
A look at the stock’s price movement, the close in the last trading session was $19.16, moving within a range at $16.49 and $19.192. The beta value (5-Year monthly) was 1.466. Turning to its 52-week performance, $38.25 and $2.70 were the 52-week high and 52-week low respectively. Overall, QNTM moved 10.38% over the past month.
Quantum BioPharma Ltd’s market cap currently stands at around $46.23 million, with investors looking forward to this quarter’s earnings report slated for on 2025-May-14.
Turning to the stock’s technical picture we see that short term indicators suggest on average that QNTM is a 50% Buy. On the other hand, the stock is on average a 100% Buy as suggested by medium term indicators while long term indicators are putting the stock in 100% Buy category.
QNTM’s current price about -18.47% and 18.86% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 46.50, while 7-day volatility ratio is 13.41% and 18.25% in the 30-day chart. Further, Quantum BioPharma Ltd (QNTM) has a beta value of 0.70.
If we refocus on Quantum BioPharma Ltd (NASDAQ:QNTM), historical trading data shows that trading volumes averaged 0.45 over the past 10 days and 244.08K over the past 3 months. The company’s latest data on shares outstanding shows there are 2.71 million shares.
Also important is the data on short interest which shows that short shares stood at 0.14 million on 2025-06-13, giving us a short ratio of 0.51. The data shows that as of 2025-06-13 short interest in Quantum BioPharma Ltd (QNTM) stood at 490.00002 of shares outstanding, with shares short rising to 70223.0 registered in 2025-05-15. Current price change has pushed the stock 91.59% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the QNTM stock continues to rise going into the next quarter.
